Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01435577 · ClinicalTrials.gov registry record · Phase 2
Intravenous Tapentadol in Post-Bunionectomy Pain
A Phase 2 study of Pain and Bunion, sponsored by Grünenthal.
- Completed
- Registry status
- Phase 2
- Development phase
- 177
- Enrollment target
- 1
- Study location
NCT01435577 is a Phase 2 study of Pain and Bunion that has completed, run by Grünenthal. The registered enrollment target is 177 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01435577, a Phase 2 study of Pain and Bunion, has completed, sponsored by Grünenthal.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 177 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this trial is to established the safety and efficacy of multiple dose treatment with tapentadol IV in an adult population with moderate to severe pain following bunionectomy.
Interventions
- DRUG Matching Placebo
- DRUG Tapentadol
Study Locations (1)
Utah
- Jean Brown Research - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01435577
The ClinicalTrials.gov registry entry for NCT01435577 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (42% lower). The listed sponsor is Grünenthal, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Matching Placebo is the first listed.
NCT01435577 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT01435577 about?
NCT01435577 is a clinical study titled "Intravenous Tapentadol in Post-Bunionectomy Pain". The purpose of this trial is to established the safety and efficacy of multiple dose treatment with tapentadol IV in an adult population with moderate to severe pain following bunionectomy.
What is the current status of trial NCT01435577?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 177 participants. The study started on 2011-09. Estimated completion is 2012-02.
What conditions does trial NCT01435577 study?
This clinical trial studies the following conditions: Pain, Bunion.
What interventions are being tested in trial NCT01435577?
The interventions under investigation include: Matching Placebo (DRUG), Tapentadol (DRUG).
Who is sponsoring clinical trial NCT01435577?
This trial is sponsored by Grünenthal, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01435577 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
RECRUITING · Phase 2
-
Neural Correlates of Hypoalgesia Driven by Observation
RECRUITING · Phase 2
-
Cannabis for Palliative Care in Cancer
RECRUITING · Phase 2
-
Pain After Buffered Vs Non Buffered Articaine
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.